News
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
Neither UTMB nor Moderna has confirmed the nature of the project included in the announcement, or how much funding is being ...
5h
Lohud.com, Westchester County on MSNRFK Jr. is winding down mRNA vaccine development. What does that mean for vaccines in NY?Federal vaccine policy changes under RFK Jr. have some concerned health insurance will not cover COVID shots. A bill in NY ...
Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...
The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.
Research that helped develop mRNA vaccines won the Nobel Prize in Physiology or Medicine in 2023. Members of the scientific community are criticizing Kennedy for his decision.
Cancer vaccines in development rely on mRNA technology under attack by RFK Jr. “I am concerned that this could bleed over," ...
Kennedy’s newest decision comes amid a string of vaccine pullbacks at the health department in recent months. In May, he said ...
The move has thrilled people in the vaccine sceptic community, including Mary Holland, chief executive of Children's Health ...
The US Department of Health and Human Services led by Robert F Kennedy Jr. has announced to slash $500 million in funding for ...
22h
Zacks.com on MSNBMY Stock Trades Near 52-Week Low: Time to Buy or Sell?BMY trims earnings outlook despite revenue beat and upbeat drug sales, sending shares to a 52-week low before a rebound. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results